Regeneron Pharmaceuticals Inc v Kymab Ltd and another

Patent – Infringement. The Patents Court made rulings in a claim concerning transgenic mice that could be used as platforms for therapeutic antibody discovery. In dismissing the claim of Regeneron Pharmaceuticals, the court held that the defendants' counterclaim for insufficiency in the patent succeeded, and hence all the patents in issue were invalid.

Category: